<DOC>
	<DOCNO>NCT00487955</DOCNO>
	<brief_summary>The purpose study evaluate metabolic contribution human microbiota rest energy expenditure</brief_summary>
	<brief_title>The Metabolic Contribution Human Microbiota Resting Energy Expenditure</brief_title>
	<detailed_description>There &gt; 500 million adult human world overweight [ body mass index ( BMI ) 25.0-29.9 kg/m2 ] 250 million obese ( BMI 30 kg/m2 ) . This grow epidemic threatens industrialize develop country accompany worldwide increase obesity-related disorder , include type II diabetes , hypertension , cardiovascular pathology , nonalcoholic fatty liver disease . In United States , 64 % adult overweight obese , prompt Surgeon General designate condition important public health challenge time . The worldwide obesity epidemic stimulating effort identify host environmental factor affect energy balance . The Human gut contain immense number microorganism , collectively know microbiota . This community consist least 1013 citizen , dominate anaerobic bacteria , include 500-1,000 specie whose collective genome estimate contain 100 time gene human genome . The microbiota view metabolic `` organ '' exquisitely tune physiology performs function evolve . These function include ability process otherwise indigestible component diet , plant polysaccharide , therefore may impact energy balance . Comparisons distal gut microbiota genetically obese mouse lean littermates , well obese lean human volunteer reveal obesity associate change relative abundance two dominant bacterial division , Bacteroidetes Firmicutes . Turnbaugh et al demonstrated metagenomic biochemical analysis change affect metabolic potential mouse gut microbiota . Furthermore , trait transmissible : colonization germ-free mouse 'obese microbiota ' result significantly great increase total body fat colonization 'lean microbiota ' . These result identify gut microbiota additional contributing factor pathophysiology obesity . It suggest , therefore , obese microbiome increase capacity harvest energy diet .</detailed_description>
	<mesh_term>Gastritis</mesh_term>
	<criteria>Inclusion criterion 40 patient refers helicobacter pylori treatment Aged 2060 year old 22 Kg/m2 ≤ BMI ≤ 30 Kg/m2 Functional GI trace permanent stool number Keeping permanent diet Written inform consent Stated availability throughout study period Mental ability understand follow protocol Exclusion criterion Use laxatives Confirmed GI tract infection inflammatory bowel disease Any major chronic illness Pregnancy Participation clinical trial Use oral intravenous antibiotic 8 week prior recruitment</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>gastritis</keyword>
	<keyword>helicobacter pylorus</keyword>
	<keyword>REE</keyword>
	<keyword>patient gastritis refers helicobacter pylori treatment</keyword>
</DOC>